English

resTORbio, Inc.

EDGAR

ACET Quarterly report (10-Q) · filed 2026-08-05

48 filing records in this dataset, filed from 2017-12-29 to 2026-08-05. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Cash and cash equivalents: 33.1 million USD 2026-06-30 Source
Exact value

33131000 USD
Long-term debt including current maturities: Not available
Shares outstanding: 9.36 million shares 2026-06-30 Source
Exact value

9361371 shares

Reported share-count change

-88.76% · -73.9 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

83252520 shares · 2025-06-30· Source
9361371 shares · 2026-06-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Net income

-99 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Net income: -26856000 USD · 2025-07-01 – 2025-09-30 Source
Net income: -116803000 USD · 2025-01-01 – 2025-12-31 Source
Net income: -86287000 USD · 2025-01-01 – 2025-09-30 Source
Net income: -20244000 USD · 2026-01-01 – 2026-03-31 Source
Net income: -21358000 USD · 2026-04-01 – 2026-06-30 Source

Operating cash flow

-84.5 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Operating cash flow: -74337000 USD · 2025-01-01 – 2025-09-30 Source
Operating cash flow: -52030000 USD · 2025-01-01 – 2025-06-30 Source
Operating cash flow: -95246000 USD · 2025-01-01 – 2025-12-31 Source
Operating cash flow: -74337000 USD · 2025-01-01 – 2025-09-30 Source
Operating cash flow: -21490000 USD · 2026-01-01 – 2026-03-31 Source
Operating cash flow: -41313000 USD · 2026-01-01 – 2026-06-30 Source
Operating cash flow: -21490000 USD · 2026-01-01 – 2026-03-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-08-05.

Financial data available through: 2025-12-31.

Coverage by financial measure

revenue: No compatible figures in this window
Operating income: 9 of 11 periods available· newest 2025-12-31
Net income: 9 of 11 periods available· newest 2025-12-31
Operating cash flow: 9 of 11 periods available· newest 2025-12-31
Capital expenditure: 9 of 11 periods available· newest 2025-12-31
Total assets: 9 of 11 periods available· newest 2025-12-31
Total liabilities: 9 of 11 periods available· newest 2025-12-31
Current assets: 9 of 11 periods available· newest 2025-12-31
Current liabilities: 9 of 11 periods available· newest 2025-12-31
Cash and cash equivalents: 9 of 11 periods available· newest 2025-12-31
long term debt: No compatible figures in this window
Shares outstanding: 9 of 11 periods available· newest 2025-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Net income
+USD 319,000

Prior period

−USD 117.12 million

2024-01-01 – 2024-12-31
Current period

−USD 116.8 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

-116803000 − -117122000 = 319000 USD

-117122000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
-116803000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · resTORbio, Inc. · 2025-12-31 resTORbio, Inc. (edgar:1720580) Year-over-year change in Net income: 319000 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T15:45:13Z Snapshot: d132336bf1c55cd837472fdd3d369d2209f37b61b0b7d99fce024c8bbd6cd4e1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1720580?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -116803000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1720580/000172058026000008/acet-20251231.htm#3194410 Filing: 000172058026000008 Input fundies:NetIncome: -117122000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1720580/000172058026000008/acet-20251231.htm#3196174 Filing: 000172058026000008
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 2.87 million

Prior period

−USD 92.38 million

2024-01-01 – 2024-12-31
Current period

−USD 95.25 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

-95246000 − -92378000 = -2868000 USD

-92378000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
-95246000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · resTORbio, Inc. · 2025-12-31 resTORbio, Inc. (edgar:1720580) Year-over-year change in Operating cash flow: -2868000 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T15:45:13Z Snapshot: d132336bf1c55cd837472fdd3d369d2209f37b61b0b7d99fce024c8bbd6cd4e1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1720580?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -95246000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1720580/000172058026000008/acet-20251231.htm#1959039 Filing: 000172058026000008 Input fundies:OperatingCashFlow: -92378000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1720580/000172058026000008/acet-20251231.htm#1960919 Filing: 000172058026000008
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+55.5%

Prior period

USD 1.12 million

2024-01-01 – 2024-12-31
Current period

USD 1.74 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

1738000 − 1118000 = 620000 USD

1118000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
1738000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · resTORbio, Inc. · 2025-12-31 resTORbio, Inc. (edgar:1720580) Year-over-year change in Capital expenditure: 620000 USD Concept: fundies:CapitalExpenditure Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T15:45:13Z Snapshot: d132336bf1c55cd837472fdd3d369d2209f37b61b0b7d99fce024c8bbd6cd4e1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1720580?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 1738000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1720580/000172058026000008/acet-20251231.htm#1973791 Filing: 000172058026000008 Input fundies:CapitalExpenditure: 1118000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1720580/000172058026000008/acet-20251231.htm#1975661 Filing: 000172058026000008
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Revenue.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

Revenue is not reported for this company, so its costs cannot be shown as a share of it.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

Not enough comparable data to show this history.

Values and sources

Revenue values and source evidence
Period	Series	Value	Source evidence

Revenue growth

Change in revenue from the same financial period one year earlier.

Not enough comparable data to show this history.

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Not enough comparable data to show this history.

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence

Operating cash flow

Cash generated by the company’s normal business operations.

Not enough comparable data to show this history.

Values and sources

Operating cash flow values and source evidence
Period	Series	Value	Source evidence

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Not enough comparable data to show this history.

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence

Current assets to current liabilities

Current assets divided by current liabilities.

Not enough comparable data to show this history.

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2017 2017-01-01 – 2017-12-31	−USD 33.78 million Exact value Exact value: -33778000 USD 2017-01-01 – 2017-12-31: -33778000 USD Inspect Net Income Open source Share or cite Citation for Net Income · resTORbio, Inc. · 2017-12-31 resTORbio, Inc. (edgar:1720580) Net Income: -33778000 USD Concept: fundies:NetIncome Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T15:45:13Z Snapshot: d132336bf1c55cd837472fdd3d369d2209f37b61b0b7d99fce024c8bbd6cd4e1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1720580/explain?concept=fundies%3ANetIncome&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:NetIncome: -33778000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1720580/000119312520176277/torc-20200331.xml#111542 Filing: 000119312520176277 The citation records this snapshot. The page link may show a newer release later.	−USD 10.99 million Exact value Exact value: -10985000 USD 2017-01-01 – 2017-12-31: -10985000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · resTORbio, Inc. · 2017-12-31 resTORbio, Inc. (edgar:1720580) Operating Cash Flow: -10985000 USD Concept: fundies:OperatingCashFlow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T15:45:13Z Snapshot: d132336bf1c55cd837472fdd3d369d2209f37b61b0b7d99fce024c8bbd6cd4e1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1720580/explain?concept=fundies%3AOperatingCashFlow&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -10985000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1720580/000119312520176277/torc-20200331.xml#113165 Filing: 000119312520176277 The citation records this snapshot. The page link may show a newer release later.	USD 44,000 Exact value Exact value: 44000 USD 2017-01-01 – 2017-12-31: 44000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · resTORbio, Inc. · 2017-12-31 resTORbio, Inc. (edgar:1720580) Capital Expenditure: 44000 USD Concept: fundies:CapitalExpenditure Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T15:45:13Z Snapshot: d132336bf1c55cd837472fdd3d369d2209f37b61b0b7d99fce024c8bbd6cd4e1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1720580/explain?concept=fundies%3ACapitalExpenditure&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 44000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1720580/000119312520176277/torc-20200331.xml#112615 Filing: 000119312520176277 The citation records this snapshot. The page link may show a newer release later.	−USD 11.03 million Calculation and evidence -10985000 − 44000 USD Exact free cash flow: -11029000 USD 2017-01-01 – 2017-12-31: -10985000 USD · Inspect Operating Cash Flow · Source 2017-01-01 – 2017-12-31: 44000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · resTORbio, Inc. · 2017-12-31 resTORbio, Inc. (edgar:1720580) Free cash flow: -11029000 USD Concept: free-cash-flow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T15:45:13Z Snapshot: d132336bf1c55cd837472fdd3d369d2209f37b61b0b7d99fce024c8bbd6cd4e1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1720580?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -10985000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1720580/000119312520176277/torc-20200331.xml#113165 Filing: 000119312520176277 Input fundies:CapitalExpenditure: 44000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1720580/000119312520176277/torc-20200331.xml#112615 Filing: 000119312520176277 The citation records this snapshot. The page link may show a newer release later.
2018 2018-01-01 – 2018-12-31	−USD 9.3 million Exact value Exact value: -9299000 USD 2018-01-01 – 2018-12-31: -9299000 USD Inspect Net Income Open source Share or cite Citation for Net Income · resTORbio, Inc. · 2018-12-31 resTORbio, Inc. (edgar:1720580) Net Income: -9299000 USD Concept: fundies:NetIncome Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T15:45:13Z Snapshot: d132336bf1c55cd837472fdd3d369d2209f37b61b0b7d99fce024c8bbd6cd4e1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1720580/explain?concept=fundies%3ANetIncome&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:NetIncome: -9299000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1720580/000156459021012664/acet-10k_20201231.htm#2225658 Filing: 000156459021012664 The citation records this snapshot. The page link may show a newer release later.	−USD 18.18 million Exact value Exact value: -18180000 USD 2018-01-01 – 2018-12-31: -18180000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · resTORbio, Inc. · 2018-12-31 resTORbio, Inc. (edgar:1720580) Operating Cash Flow: -18180000 USD Concept: fundies:OperatingCashFlow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T15:45:13Z Snapshot: d132336bf1c55cd837472fdd3d369d2209f37b61b0b7d99fce024c8bbd6cd4e1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1720580/explain?concept=fundies%3AOperatingCashFlow&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -18180000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1720580/000156459021012664/acet-10k_20201231.htm#2650737 Filing: 000156459021012664 The citation records this snapshot. The page link may show a newer release later.	USD 876,000 Exact value Exact value: 876000 USD 2018-01-01 – 2018-12-31: 876000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · resTORbio, Inc. · 2018-12-31 resTORbio, Inc. (edgar:1720580) Capital Expenditure: 876000 USD Concept: fundies:CapitalExpenditure Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T15:45:13Z Snapshot: d132336bf1c55cd837472fdd3d369d2209f37b61b0b7d99fce024c8bbd6cd4e1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1720580/explain?concept=fundies%3ACapitalExpenditure&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 876000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1720580/000156459021012664/acet-10k_20201231.htm#2683961 Filing: 000156459021012664 The citation records this snapshot. The page link may show a newer release later.	−USD 19.06 million Calculation and evidence -18180000 − 876000 USD Exact free cash flow: -19056000 USD 2018-01-01 – 2018-12-31: -18180000 USD · Inspect Operating Cash Flow · Source 2018-01-01 – 2018-12-31: 876000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · resTORbio, Inc. · 2018-12-31 resTORbio, Inc. (edgar:1720580) Free cash flow: -19056000 USD Concept: free-cash-flow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T15:45:13Z Snapshot: d132336bf1c55cd837472fdd3d369d2209f37b61b0b7d99fce024c8bbd6cd4e1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1720580?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -18180000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1720580/000156459021012664/acet-10k_20201231.htm#2650737 Filing: 000156459021012664 Input fundies:CapitalExpenditure: 876000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1720580/000156459021012664/acet-10k_20201231.htm#2683961 Filing: 000156459021012664 The citation records this snapshot. The page link may show a newer release later.
2019 2019-01-01 – 2019-12-31	−USD 28.14 million Exact value Exact value: -28138000 USD 2019-01-01 – 2019-12-31: -28138000 USD Inspect Net Income Open source Share or cite Citation for Net Income · resTORbio, Inc. · 2019-12-31 resTORbio, Inc. (edgar:1720580) Net Income: -28138000 USD Concept: fundies:NetIncome Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T15:45:13Z Snapshot: d132336bf1c55cd837472fdd3d369d2209f37b61b0b7d99fce024c8bbd6cd4e1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1720580/explain?concept=fundies%3ANetIncome&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:NetIncome: -28138000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1720580/000156459021012664/acet-10k_20201231.htm#2354679 Filing: 000156459021012664 The citation records this snapshot. The page link may show a newer release later.	−USD 27.88 million Exact value Exact value: -27882000 USD 2019-01-01 – 2019-12-31: -27882000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · resTORbio, Inc. · 2019-12-31 resTORbio, Inc. (edgar:1720580) Operating Cash Flow: -27882000 USD Concept: fundies:OperatingCashFlow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T15:45:13Z Snapshot: d132336bf1c55cd837472fdd3d369d2209f37b61b0b7d99fce024c8bbd6cd4e1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1720580/explain?concept=fundies%3AOperatingCashFlow&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -27882000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1720580/000156459021012664/acet-10k_20201231.htm#2648774 Filing: 000156459021012664 The citation records this snapshot. The page link may show a newer release later.	USD 1.07 million Exact value Exact value: 1070000 USD 2019-01-01 – 2019-12-31: 1070000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · resTORbio, Inc. · 2019-12-31 resTORbio, Inc. (edgar:1720580) Capital Expenditure: 1070000 USD Concept: fundies:CapitalExpenditure Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T15:45:13Z Snapshot: d132336bf1c55cd837472fdd3d369d2209f37b61b0b7d99fce024c8bbd6cd4e1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1720580/explain?concept=fundies%3ACapitalExpenditure&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1070000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1720580/000156459021012664/acet-10k_20201231.htm#2682074 Filing: 000156459021012664 The citation records this snapshot. The page link may show a newer release later.	−USD 28.95 million Calculation and evidence -27882000 − 1070000 USD Exact free cash flow: -28952000 USD 2019-01-01 – 2019-12-31: -27882000 USD · Inspect Operating Cash Flow · Source 2019-01-01 – 2019-12-31: 1070000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · resTORbio, Inc. · 2019-12-31 resTORbio, Inc. (edgar:1720580) Free cash flow: -28952000 USD Concept: free-cash-flow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T15:45:13Z Snapshot: d132336bf1c55cd837472fdd3d369d2209f37b61b0b7d99fce024c8bbd6cd4e1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1720580?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -27882000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1720580/000156459021012664/acet-10k_20201231.htm#2648774 Filing: 000156459021012664 Input fundies:CapitalExpenditure: 1070000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1720580/000156459021012664/acet-10k_20201231.htm#2682074 Filing: 000156459021012664 The citation records this snapshot. The page link may show a newer release later.
2020 2020-01-01 – 2020-12-31	−USD 36.68 million Exact value Exact value: -36678000 USD 2020-01-01 – 2020-12-31: -36678000 USD Inspect Net Income Open source Share or cite Citation for Net Income · resTORbio, Inc. · 2020-12-31 resTORbio, Inc. (edgar:1720580) Net Income: -36678000 USD Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T15:45:13Z Snapshot: d132336bf1c55cd837472fdd3d369d2209f37b61b0b7d99fce024c8bbd6cd4e1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1720580/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:NetIncome: -36678000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1720580/000095017022003753/acet-20211231.htm#1975555 Filing: 000095017022003753 The citation records this snapshot. The page link may show a newer release later.	−USD 41.55 million Exact value Exact value: -41552000 USD 2020-01-01 – 2020-12-31: -41552000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · resTORbio, Inc. · 2020-12-31 resTORbio, Inc. (edgar:1720580) Operating Cash Flow: -41552000 USD Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T15:45:13Z Snapshot: d132336bf1c55cd837472fdd3d369d2209f37b61b0b7d99fce024c8bbd6cd4e1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1720580/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -41552000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1720580/000095017022003753/acet-20211231.htm#2211891 Filing: 000095017022003753 The citation records this snapshot. The page link may show a newer release later.	USD 990,000 Exact value Exact value: 990000 USD 2020-01-01 – 2020-12-31: 990000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · resTORbio, Inc. · 2020-12-31 resTORbio, Inc. (edgar:1720580) Capital Expenditure: 990000 USD Concept: fundies:CapitalExpenditure Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T15:45:13Z Snapshot: d132336bf1c55cd837472fdd3d369d2209f37b61b0b7d99fce024c8bbd6cd4e1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1720580/explain?concept=fundies%3ACapitalExpenditure&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 990000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1720580/000095017022003753/acet-20211231.htm#2237484 Filing: 000095017022003753 The citation records this snapshot. The page link may show a newer release later.	−USD 42.54 million Calculation and evidence -41552000 − 990000 USD Exact free cash flow: -42542000 USD 2020-01-01 – 2020-12-31: -41552000 USD · Inspect Operating Cash Flow · Source 2020-01-01 – 2020-12-31: 990000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · resTORbio, Inc. · 2020-12-31 resTORbio, Inc. (edgar:1720580) Free cash flow: -42542000 USD Concept: free-cash-flow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T15:45:13Z Snapshot: d132336bf1c55cd837472fdd3d369d2209f37b61b0b7d99fce024c8bbd6cd4e1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1720580?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -41552000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1720580/000095017022003753/acet-20211231.htm#2211891 Filing: 000095017022003753 Input fundies:CapitalExpenditure: 990000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1720580/000095017022003753/acet-20211231.htm#2237484 Filing: 000095017022003753 The citation records this snapshot. The page link may show a newer release later.
2021 2021-01-01 – 2021-12-31	−USD 62 million Exact value Exact value: -61999000 USD 2021-01-01 – 2021-12-31: -61999000 USD Inspect Net Income Open source Share or cite Citation for Net Income · resTORbio, Inc. · 2021-12-31 resTORbio, Inc. (edgar:1720580) Net Income: -61999000 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T15:45:13Z Snapshot: d132336bf1c55cd837472fdd3d369d2209f37b61b0b7d99fce024c8bbd6cd4e1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1720580/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:NetIncome: -61999000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1720580/000095017023008130/acet-20221231.htm#1869146 Filing: 000095017023008130 The citation records this snapshot. The page link may show a newer release later.	−USD 51.05 million Exact value Exact value: -51052000 USD 2021-01-01 – 2021-12-31: -51052000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · resTORbio, Inc. · 2021-12-31 resTORbio, Inc. (edgar:1720580) Operating Cash Flow: -51052000 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T15:45:13Z Snapshot: d132336bf1c55cd837472fdd3d369d2209f37b61b0b7d99fce024c8bbd6cd4e1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1720580/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -51052000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1720580/000095017023008130/acet-20221231.htm#2097751 Filing: 000095017023008130 The citation records this snapshot. The page link may show a newer release later.	USD 13.05 million Exact value Exact value: 13046000 USD 2021-01-01 – 2021-12-31: 13046000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · resTORbio, Inc. · 2021-12-31 resTORbio, Inc. (edgar:1720580) Capital Expenditure: 13046000 USD Concept: fundies:CapitalExpenditure Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T15:45:13Z Snapshot: d132336bf1c55cd837472fdd3d369d2209f37b61b0b7d99fce024c8bbd6cd4e1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1720580/explain?concept=fundies%3ACapitalExpenditure&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 13046000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1720580/000095017023008130/acet-20221231.htm#2114698 Filing: 000095017023008130 The citation records this snapshot. The page link may show a newer release later.	−USD 64.1 million Calculation and evidence -51052000 − 13046000 USD Exact free cash flow: -64098000 USD 2021-01-01 – 2021-12-31: -51052000 USD · Inspect Operating Cash Flow · Source 2021-01-01 – 2021-12-31: 13046000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · resTORbio, Inc. · 2021-12-31 resTORbio, Inc. (edgar:1720580) Free cash flow: -64098000 USD Concept: free-cash-flow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T15:45:13Z Snapshot: d132336bf1c55cd837472fdd3d369d2209f37b61b0b7d99fce024c8bbd6cd4e1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1720580?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -51052000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1720580/000095017023008130/acet-20221231.htm#2097751 Filing: 000095017023008130 Input fundies:CapitalExpenditure: 13046000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1720580/000095017023008130/acet-20221231.htm#2114698 Filing: 000095017023008130 The citation records this snapshot. The page link may show a newer release later.
2022 2022-01-01 – 2022-12-31	−USD 69.79 million Exact value Exact value: -69790000 USD 2022-01-01 – 2022-12-31: -69790000 USD Inspect Net Income Open source Share or cite Citation for Net Income · resTORbio, Inc. · 2022-12-31 resTORbio, Inc. (edgar:1720580) Net Income: -69790000 USD Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T15:45:13Z Snapshot: d132336bf1c55cd837472fdd3d369d2209f37b61b0b7d99fce024c8bbd6cd4e1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1720580/explain?concept=fundies%3ANetIncome&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:NetIncome: -69790000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1720580/000095017024033482/acet-20231231.htm#1464959 Filing: 000095017024033482 The citation records this snapshot. The page link may show a newer release later.	−USD 44.77 million Exact value Exact value: -44765000 USD 2022-01-01 – 2022-12-31: -44765000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · resTORbio, Inc. · 2022-12-31 resTORbio, Inc. (edgar:1720580) Operating Cash Flow: -44765000 USD Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T15:45:13Z Snapshot: d132336bf1c55cd837472fdd3d369d2209f37b61b0b7d99fce024c8bbd6cd4e1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1720580/explain?concept=fundies%3AOperatingCashFlow&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -44765000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1720580/000095017024033482/acet-20231231.htm#1569913 Filing: 000095017024033482 The citation records this snapshot. The page link may show a newer release later.	USD 16.78 million Exact value Exact value: 16782000 USD 2022-01-01 – 2022-12-31: 16782000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · resTORbio, Inc. · 2022-12-31 resTORbio, Inc. (edgar:1720580) Capital Expenditure: 16782000 USD Concept: fundies:CapitalExpenditure Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T15:45:13Z Snapshot: d132336bf1c55cd837472fdd3d369d2209f37b61b0b7d99fce024c8bbd6cd4e1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1720580/explain?concept=fundies%3ACapitalExpenditure&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 16782000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1720580/000095017024033482/acet-20231231.htm#1574937 Filing: 000095017024033482 The citation records this snapshot. The page link may show a newer release later.	−USD 61.55 million Calculation and evidence -44765000 − 16782000 USD Exact free cash flow: -61547000 USD 2022-01-01 – 2022-12-31: -44765000 USD · Inspect Operating Cash Flow · Source 2022-01-01 – 2022-12-31: 16782000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · resTORbio, Inc. · 2022-12-31 resTORbio, Inc. (edgar:1720580) Free cash flow: -61547000 USD Concept: free-cash-flow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T15:45:13Z Snapshot: d132336bf1c55cd837472fdd3d369d2209f37b61b0b7d99fce024c8bbd6cd4e1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1720580?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -44765000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1720580/000095017024033482/acet-20231231.htm#1569913 Filing: 000095017024033482 Input fundies:CapitalExpenditure: 16782000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1720580/000095017024033482/acet-20231231.htm#1574937 Filing: 000095017024033482 The citation records this snapshot. The page link may show a newer release later.
2023 2023-01-01 – 2023-12-31	−USD 142.66 million Exact value Exact value: -142658000 USD 2023-01-01 – 2023-12-31: -142658000 USD Inspect Net Income Open source Share or cite Citation for Net Income · resTORbio, Inc. · 2023-12-31 resTORbio, Inc. (edgar:1720580) Net Income: -142658000 USD Concept: fundies:NetIncome Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T15:45:13Z Snapshot: d132336bf1c55cd837472fdd3d369d2209f37b61b0b7d99fce024c8bbd6cd4e1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1720580/explain?concept=fundies%3ANetIncome&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:NetIncome: -142658000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1720580/000095017025034587/acet-20241231.htm#3889715 Filing: 000095017025034587 The citation records this snapshot. The page link may show a newer release later.	−USD 93.72 million Exact value Exact value: -93717000 USD 2023-01-01 – 2023-12-31: -93717000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · resTORbio, Inc. · 2023-12-31 resTORbio, Inc. (edgar:1720580) Operating Cash Flow: -93717000 USD Concept: fundies:OperatingCashFlow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T15:45:13Z Snapshot: d132336bf1c55cd837472fdd3d369d2209f37b61b0b7d99fce024c8bbd6cd4e1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1720580/explain?concept=fundies%3AOperatingCashFlow&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -93717000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1720580/000095017025034587/acet-20241231.htm#2823655 Filing: 000095017025034587 The citation records this snapshot. The page link may show a newer release later.	USD 4.46 million Exact value Exact value: 4464000 USD 2023-01-01 – 2023-12-31: 4464000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · resTORbio, Inc. · 2023-12-31 resTORbio, Inc. (edgar:1720580) Capital Expenditure: 4464000 USD Concept: fundies:CapitalExpenditure Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T15:45:13Z Snapshot: d132336bf1c55cd837472fdd3d369d2209f37b61b0b7d99fce024c8bbd6cd4e1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1720580/explain?concept=fundies%3ACapitalExpenditure&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 4464000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1720580/000095017025034587/acet-20241231.htm#2837253 Filing: 000095017025034587 The citation records this snapshot. The page link may show a newer release later.	−USD 98.18 million Calculation and evidence -93717000 − 4464000 USD Exact free cash flow: -98181000 USD 2023-01-01 – 2023-12-31: -93717000 USD · Inspect Operating Cash Flow · Source 2023-01-01 – 2023-12-31: 4464000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · resTORbio, Inc. · 2023-12-31 resTORbio, Inc. (edgar:1720580) Free cash flow: -98181000 USD Concept: free-cash-flow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T15:45:13Z Snapshot: d132336bf1c55cd837472fdd3d369d2209f37b61b0b7d99fce024c8bbd6cd4e1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1720580?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -93717000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1720580/000095017025034587/acet-20241231.htm#2823655 Filing: 000095017025034587 Input fundies:CapitalExpenditure: 4464000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1720580/000095017025034587/acet-20241231.htm#2837253 Filing: 000095017025034587 The citation records this snapshot. The page link may show a newer release later.
2024 2024-01-01 – 2024-12-31	−USD 117.12 million Exact value Exact value: -117122000 USD 2024-01-01 – 2024-12-31: -117122000 USD Inspect Net Income Open source Share or cite Citation for Net Income · resTORbio, Inc. · 2024-12-31 resTORbio, Inc. (edgar:1720580) Net Income: -117122000 USD Concept: fundies:NetIncome Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T15:45:13Z Snapshot: d132336bf1c55cd837472fdd3d369d2209f37b61b0b7d99fce024c8bbd6cd4e1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1720580/explain?concept=fundies%3ANetIncome&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:NetIncome: -117122000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1720580/000172058026000008/acet-20251231.htm#3196174 Filing: 000172058026000008 The citation records this snapshot. The page link may show a newer release later.	−USD 92.38 million Exact value Exact value: -92378000 USD 2024-01-01 – 2024-12-31: -92378000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · resTORbio, Inc. · 2024-12-31 resTORbio, Inc. (edgar:1720580) Operating Cash Flow: -92378000 USD Concept: fundies:OperatingCashFlow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T15:45:13Z Snapshot: d132336bf1c55cd837472fdd3d369d2209f37b61b0b7d99fce024c8bbd6cd4e1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1720580/explain?concept=fundies%3AOperatingCashFlow&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -92378000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1720580/000172058026000008/acet-20251231.htm#1960919 Filing: 000172058026000008 The citation records this snapshot. The page link may show a newer release later.	USD 1.12 million Exact value Exact value: 1118000 USD 2024-01-01 – 2024-12-31: 1118000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · resTORbio, Inc. · 2024-12-31 resTORbio, Inc. (edgar:1720580) Capital Expenditure: 1118000 USD Concept: fundies:CapitalExpenditure Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T15:45:13Z Snapshot: d132336bf1c55cd837472fdd3d369d2209f37b61b0b7d99fce024c8bbd6cd4e1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1720580/explain?concept=fundies%3ACapitalExpenditure&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1118000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1720580/000172058026000008/acet-20251231.htm#1975661 Filing: 000172058026000008 The citation records this snapshot. The page link may show a newer release later.	−USD 93.5 million Calculation and evidence -92378000 − 1118000 USD Exact free cash flow: -93496000 USD 2024-01-01 – 2024-12-31: -92378000 USD · Inspect Operating Cash Flow · Source 2024-01-01 – 2024-12-31: 1118000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · resTORbio, Inc. · 2024-12-31 resTORbio, Inc. (edgar:1720580) Free cash flow: -93496000 USD Concept: free-cash-flow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T15:45:13Z Snapshot: d132336bf1c55cd837472fdd3d369d2209f37b61b0b7d99fce024c8bbd6cd4e1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1720580?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -92378000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1720580/000172058026000008/acet-20251231.htm#1960919 Filing: 000172058026000008 Input fundies:CapitalExpenditure: 1118000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1720580/000172058026000008/acet-20251231.htm#1975661 Filing: 000172058026000008 The citation records this snapshot. The page link may show a newer release later.
2025 2025-01-01 – 2025-12-31	−USD 116.8 million Exact value Exact value: -116803000 USD 2025-01-01 – 2025-12-31: -116803000 USD Inspect Net Income Open source Share or cite Citation for Net Income · resTORbio, Inc. · 2025-12-31 resTORbio, Inc. (edgar:1720580) Net Income: -116803000 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T15:45:13Z Snapshot: d132336bf1c55cd837472fdd3d369d2209f37b61b0b7d99fce024c8bbd6cd4e1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1720580/explain?concept=fundies%3ANetIncome&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:NetIncome: -116803000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1720580/000172058026000008/acet-20251231.htm#3194410 Filing: 000172058026000008 The citation records this snapshot. The page link may show a newer release later.	−USD 95.25 million Exact value Exact value: -95246000 USD 2025-01-01 – 2025-12-31: -95246000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · resTORbio, Inc. · 2025-12-31 resTORbio, Inc. (edgar:1720580) Operating Cash Flow: -95246000 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T15:45:13Z Snapshot: d132336bf1c55cd837472fdd3d369d2209f37b61b0b7d99fce024c8bbd6cd4e1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1720580/explain?concept=fundies%3AOperatingCashFlow&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -95246000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1720580/000172058026000008/acet-20251231.htm#1959039 Filing: 000172058026000008 The citation records this snapshot. The page link may show a newer release later.	USD 1.74 million Exact value Exact value: 1738000 USD 2025-01-01 – 2025-12-31: 1738000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · resTORbio, Inc. · 2025-12-31 resTORbio, Inc. (edgar:1720580) Capital Expenditure: 1738000 USD Concept: fundies:CapitalExpenditure Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T15:45:13Z Snapshot: d132336bf1c55cd837472fdd3d369d2209f37b61b0b7d99fce024c8bbd6cd4e1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1720580/explain?concept=fundies%3ACapitalExpenditure&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1738000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1720580/000172058026000008/acet-20251231.htm#1973791 Filing: 000172058026000008 The citation records this snapshot. The page link may show a newer release later.	−USD 96.98 million Calculation and evidence -95246000 − 1738000 USD Exact free cash flow: -96984000 USD 2025-01-01 – 2025-12-31: -95246000 USD · Inspect Operating Cash Flow · Source 2025-01-01 – 2025-12-31: 1738000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · resTORbio, Inc. · 2025-12-31 resTORbio, Inc. (edgar:1720580) Free cash flow: -96984000 USD Concept: free-cash-flow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T15:45:13Z Snapshot: d132336bf1c55cd837472fdd3d369d2209f37b61b0b7d99fce024c8bbd6cd4e1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1720580?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -95246000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1720580/000172058026000008/acet-20251231.htm#1959039 Filing: 000172058026000008 Input fundies:CapitalExpenditure: 1738000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1720580/000172058026000008/acet-20251231.htm#1973791 Filing: 000172058026000008 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

48 filings · 2,214 latest values · 2,214 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001720580, 1720580, ACET, TORC, edgar:1720580

Also known as Adicet Bio, Inc, Adicet Bio, Inc., resTORbio, Inc.

resTORbio, Inc.

Reported share-count change

Trailing twelve months

Net income

Operating cash flow

Company performance

What changed year over year

Net income

Operating cash flow

Capital expenditure

Where revenue goes

Growth

Profit and cash

Balance sheet

Cash generation